CAPN1
protein-codingcalpain 1, the group of Calpains|EF-hand domain containing
Gene summary
The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes the large subunit of the ubiquitous enzyme, calpain 1. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~31.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014827
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014827
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CAPN1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005186.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 66 | 3 | 71 | ||
| missense | 4 | 1 | 159 | 10 | 1 | 175 |
| nonsense | 12 | 8 | 1 | 21 | ||
| start loss | 0 | |||||
| frameshift | 10 | 2 | 12 | |||
| splice donor/acceptor (+/-2bp) | 6 | 6 | 11 | 23 | ||
| Total | 32 | 17 | 173 | 76 | 4 | 302 |
Highest pathogenic variant AF is 0.000105541556
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005177.2 | 21 | MANE Select | |
| Ensembl | ENSP00000279247.7 | 21 | MANE Select | |
| RefSeq | NP_001185797.1 | 21 | Standard | |
| RefSeq | NP_001185798.1 | 21 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| capn1a | Danio rerio | Structure: neuron Quality: disorganized abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Protein processing in endoplasmic reticulum - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Necroptosis - Homo sapiens (human)
- Apoptosis - Homo sapiens (human)
- Cellular senescence - Homo sapiens (human)
Biological Process
- proteolysis
- positive regulation of cell population proliferation
- regulation of macroautophagy
- receptor catabolic process
- neutrophil degranulation
Molecular Function
- endopeptidase activity
- calcium-dependent cysteine-type endopeptidase activity
- calcium ion binding
- protein binding
Cellular Component
- extracellular region
- cytoplasm
- mitochondrion
- lysosome
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000527323
- Coding exons
- 21
- Length
- 31441
- Individuals with no LoFs
- 124649
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 71
- Defined
- 124720
- p
- 0.000285
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.68 | 369 | 472 | 0.782 | 0.0000315 | 4636 |
| Missense (PolyPhen) | 135 | 194.01 | 0.69583 | 1899 | ||
| Synonymous | 2.48 | 149 | 193 | 0.773 | 0.0000134 | 1354 |
| Loss of Function | 3.16 | 23 | 46.1 | 0.499 | 0.00000257 | 470 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.0011 | notable |
| Latino/Admixed American | 0.00044 | 0.00043 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00021 | 0.00021 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00017 | 0.00017 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. {ECO:0000269|PubMed:21531719, ECO:0000269|PubMed:2400579}.;
- Disease
- DISEASE: Spastic paraplegia 76, autosomal recessive (SPG76) [MIM:616907]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:27153400}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.340
Intolerance Scores
- LoFtool
- 0.500
- RVIS EVS
- -0.33
- RVIS percentile EVS
- 30.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.624
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |